Treatment of behavioral and psychological symptoms of dementias with psychopharmaceuticals: a review

por Masopust, Jiří, Protopopová, Dita, Vališ, Martin, Pavelek, Zbyšek, Klímová, Blanka
Publicado 2018

Highly active RRMS and ocrelizumab after failure of alemtuzumab therapy

por Vališ, Martin, Ryška, Pavel, Halúsková, Simona, Klímová, Blanka, Pavelek, Zbyšek
Publicado 2020

Acupuncture in migraine prophylaxis in Czech patients: an open-label randomized controlled trial

por Musil, Frantisek, Pokladnikova, Jitka, Pavelek, Zbysek, Wang, Bo, Guan, Xin, Valis, Martin
Publicado 2018

CD4+/CD45RO+: A Potential Biomarker of the Clinical Response to Glatiramer Acetate

por Vališ, Martin, Sobíšek, Lukáš, Vyšata, Oldřich, Klímová, Blanka, Andrýs, Ctirad, Vokurková, Doris, Masopust, Jiří, Pavelek, Zbyšek
Publicado 2019

The role of the immune system and the biomarker CD3 + CD4 + CD45RA−CD62L− in the pathophysiology of migraine

por Pavelek, Zbyšek, Souček, Ondřej, Krejsek, Jan, Sobíšek, Lukáš, Klímová, Blanka, Masopust, Jiří, Kuča, Kamil, Vališ, Martin
Publicado 2020

Proteomic analysis of cerebrospinal fluid for relapsing-remitting multiple sclerosis and clinically isolated syndrome

por PAVELEK, ZBYŠEK, VYŠATA, OLDŘICH, TAMBOR, VOJTĚCH, PIMKOVÁ, KRISTÝNA, VU, DAI LONG, KUČA, KAMIL, ŠŤOURAČ, PAVEL, VALIŠ, MARTIN
Publicado 2016

The Benefits and Risks of Switching from Fingolimod to Siponimod for the Treatment of Relapsing–Remitting and Secondary Progressive Multiple Sclerosis

por Vališ, Martin, Achiron, Anat, Hartung, Hans Peter, Mareš, Jan, Tichá, Veronika, Štourač, Pavel, Halusková, Simona, Angelucci, Francesco, Pavelek, Zbyšek
Publicado 2023

Interferon Beta-1a versus Glatiramer Acetate: Changes of Innate Immunity in a Group of Women with Multiple Sclerosis

por Peterka, Marek, Valis, Martin, Soucek, Ondrej, Krejsek, Jan, Sobisek, Lukáš, Sejkorova, Ilona, Klimova, Blanka, Stourac, Pavel, Pavelek, Zbysek, Novotny, Michal
Publicado 2023

Innate Immune System and Multiple Sclerosis. Granulocyte Numbers Are Reduced in Patients Affected by Relapsing-Remitting Multiple Sclerosis during the Remission Phase

por Pavelek, Zbyšek, Angelucci, Francesco, Souček, Ondřej, Krejsek, Jan, Sobíšek, Lukáš, Klímová, Blanka, Šarláková, Jana, Halúsková, Simona, Kuča, Kamil, Vališ, Martin
Publicado 2020

In Silico Studies of Potential Selective Inhibitors of Thymidylate Kinase from Variola virus

por Garcia, Danielle R., Souza, Felipe R., Guimarães, Ana P., Valis, Martin, Pavelek, Zbyšek, Kuca, Kamil, Ramalho, Teodorico C., França, Tanos C. C.
Publicado 2021

The Concentration of Memantine in the Cerebrospinal Fluid of Alzheimer’s Disease Patients and Its Consequence to Oxidative Stress Biomarkers

por Valis, Martin, Herman, David, Vanova, Nela, Masopust, Jiri, Vysata, Oldrich, Hort, Jakub, Pavelek, Zbysek, Klimova, Blanka, Kuca, Kamil, Misik, Jan, Zdarova Karasova, Jana
Publicado 2019

Assessment of Functional Capacity of Immune System in Patients with Multiple Sclerosis using QuantiFERON Monitor

por Pavelek, Zbysek, Soucek, Ondrej, Krejsek, Jan, Sejkorova, Ilona, Vysata, Oldrich, Klimová, Blanka, Angelucci, Francesco, Stourac, Pavel, Valis, Martin, Peterka, Marek, Sobisek, Lukáš, Novotny, Michal
Publicado 2023

Analysis of the Group of Pediatric Patients With Relapsing-Remitting Multiple Sclerosis: Data From the Czech National Registry

por Vališ, Martin, Pavelek, Zbyšek, Novotný, Michal, Klímová, Blanka, Šarláková, Jana, Halúsková, Simona, Peterka, Marek, Štětkárová, Ivana, Štourač, Pavel, Mareš, Jan, Hradílek, Pavel, Ampapa, Radek, Vachová, Marta, Recmanová, Eva, Meluzínová, Eva
Publicado 2022

Comparison of Therapies in MS Patients After the First Demyelinating Event in Real Clinical Practice in the Czech Republic: Data From the National Registry ReMuS

por Pavelek, Zbyšek, Sobíšek, Lukáš, Šarláková, Jana, Potužník, Pavel, Peterka, Marek, Štětkárová, Ivana, Štourač, Pavel, Mareš, Jan, Hradílek, Pavel, Ampapa, Radek, Grünermelová, Markéta, Vachová, Marta, Recmanová, Eva, Angelucci, Francesco, Halúsková, Simona, Vališ, Martin
Publicado 2021